Clinical Trial Update: Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update evaluating the combination of chemotherapy with amifostine in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Chronic Myeloproliferative Disorders, Drug/Agent Toxicity by Tissue/Organ | Phase 1 | Status: UNKNOWN